COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment
- PMID: 33430745
- DOI: 10.2174/1381612827999210111185608
COVID-19 Infection: Epidemiology, Virology, Clinical Features, Diagnosis and Pharmacological Treatment
Abstract
Coronavirus was first discovered during the year 1930 and since then, various coronaviruses like HKU1, MERS-CoV , NL63 and SARS-CoV-2 have been found to infect humans. The COVID-19 pandemic caused by SARS-CoV-2 is spreading at an alarming rate, thereby creating a health emergency around the world. SARS-CoV2 is reported to be originated from a wet animal market of Wuhan, China. Since then, the world is searching for effective ways to manage and treat the COVID-19 infection. The infections have already multiplied with several folds compared to the number of persons infected by Middle East Respiratory Syndrome Coronavirus and Severe Acute Respiratory Syndrome. In order to fill the gap of knowledge about this virus, several pieces of evidence are required to control it so more lives could be saved. The present review is based on the publicly available literature in order to explore the knowledge regarding epidemiology, virology, diagnosis, clinical features, pharmacological and therapeutic ways to treat the novel coronavirus. This can be helpful in offering novel insights and potential therapeutics for fighting this disease.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; clinical trial.; cytokine syndrome; vaccines.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Human and novel coronavirus infections in children: a review.Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25. Paediatr Int Child Health. 2021. PMID: 32584199 Review.
-
Coronaviruses - a new old menace.Postepy Biochem. 2021 Jan 5;66(4):303-308. doi: 10.18388/pb.2020_357. Print 2020 Dec 31. Postepy Biochem. 2021. PMID: 33470077 Review.
-
Recent Patents and Advances on Nanotechnologies against Coronavirus.Recent Pat Nanotechnol. 2021;15(4):322-330. doi: 10.2174/1872210514666201110125536. Recent Pat Nanotechnol. 2021. PMID: 33172382 Review.
-
COVID-19: a conundrum to decipher.Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378. Eur Rev Med Pharmacol Sci. 2020. PMID: 32495923
-
Potential Drug Strategies to Target Coronaviruses.Adv Exp Med Biol. 2021;1352:111-124. doi: 10.1007/978-3-030-85109-5_7. Adv Exp Med Biol. 2021. PMID: 35132597
Cited by
-
Skin Manifestation of SARS-CoV-2: The Italian Experience.J Clin Med. 2021 Apr 8;10(8):1566. doi: 10.3390/jcm10081566. J Clin Med. 2021. PMID: 33917774 Free PMC article.
-
Sorption of SARS-CoV-2 Virus Particles to the Surface of Microplastics Released during Washing Processes.Int J Environ Res Public Health. 2021 Dec 28;19(1):281. doi: 10.3390/ijerph19010281. Int J Environ Res Public Health. 2021. PMID: 35010541 Free PMC article.
-
A dynamic model for elevator operation-induced spread of a respiratory infectious disease in an apartment building.Heliyon. 2023 Feb 21;9(3):e13612. doi: 10.1016/j.heliyon.2023.e13612. eCollection 2023 Mar. Heliyon. 2023. PMID: 36873541 Free PMC article.
-
Animal models for COVID-19: advances, gaps and perspectives.Signal Transduct Target Ther. 2022 Jul 7;7(1):220. doi: 10.1038/s41392-022-01087-8. Signal Transduct Target Ther. 2022. PMID: 35798699 Free PMC article. Review.
-
The prevalence of AstraZeneca COVID-19 vaccine side effects among Nigist Eleni Mohammed memorial comprehensive specialized hospital health workers. Cross sectional survey.PLoS One. 2022 Jun 24;17(6):e0265140. doi: 10.1371/journal.pone.0265140. eCollection 2022. PLoS One. 2022. PMID: 35749520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous